STATOpinion

How the Centers for Medicare and Medicaid Services became the shining light of Trump’s second term

There is plenty of bad coming out of the federal government on health care. CMS is the exception, write Ezekiel J. Emanuel ...
STAT

If you have Alzheimer’s disease, who will take part in your care?

Doctors working with patients with Alzheimer’s and other causes of dementia must ask: Who will take part in your care?
STAT

Federal government turns to fresher data to rein in Medicare Advantage upcoding

The health insurance industry was caught off guard by the federal government’s recent proposal to keep next year’s payments to Medicare Advantage plans mostly flat, and to change a controversial ...
STATOpinion

STAT readers respond on the ethics of gender-affirming care for minors, the new food pyramid, and more

Authors of HHS report criticize recent STAT op-ed on gender-affirming care for minors for using “scare tactics.” ...
STATOpinion

As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study

As a scientist, I am disgusted. As an NFL widow who witnessed unimaginable suffering, I am furious,” writes Eleanor M.
STAT

TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics

WASHINGTON — President Trump said his administration’s new TrumpRx website will offer the cheapest prices in the world for 43 ...
STAT

Statins don’t cause most of the side effects on package warnings, study finds

Many people who should be taking statins avoid them for fear of side effects. A large new study says most of those side ...
STAT

China criticizes U.S. for WHO pullout, accusing it of sidestepping international law

China criticized the United States for withdrawing from the WHO, saying countries should not place domestic politics ahead of ...
STAT

‘Moonshot’ agency ARPA-H lays off staff meant to commercialize breakthroughs

ARPA-H, the “moonshot” biomedical agency established under the Biden administration, laid off staff last week, according to ...
STAT

A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
STAT

Roivant immune drug significantly outperformed placebo in treating rare skin disease

In a small trial, Roivant's immune drug significantly outperformed placebo in clearing lesions caused by a rare skin disease.
STAT

I treated children for rotavirus in Denmark. The Danish vaccine schedule is no model for the U.S.

In Denmark, pediatrician Michael Thwing once saw nearly 20 infants admitted simultaneously with rotavirus. His experience in ...